君圣泰医药（02511）于2025年12月2日公布2025年11月股份变动月报表。报告期内，公司注册股本仍为1,000,000,000股，面值每股USD 0.0001，总注册股本维持USD 100,000，未发生变动。
公司于香港联交所主板上市的已发行股份总数在本月继续保持571,325,668股，无新增发行、购回或注销，也未发生库藏股变动。报告显示公司在期内未涉任何可转换债券、权证或其他股份期权安排。
截至2025年11月30日，君圣泰医药已发行股本保持不变。公司声明已遵守香港联交所《上市规则》及相关法律规定。该月报文件由执行董事兼行政总裁刘利平博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.